Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Cipla Ltd ( (IN:CIPLA) ).
Cipla Ltd has announced the completion of its acquisition of a 100% stake in Inzpera Healthsciences Limited, making Inzpera a wholly owned subsidiary. This strategic move is expected to enhance Cipla’s market positioning and expand its portfolio in the healthcare sector, potentially benefiting stakeholders by broadening the company’s capabilities and reach.
More about Cipla Ltd
Cipla Ltd is a prominent pharmaceutical company based in India, primarily engaged in the development, manufacturing, and distribution of a wide range of pharmaceutical products. The company focuses on providing affordable medicines and healthcare solutions, with a strong presence in both domestic and international markets.
Average Trading Volume: 71,420
Technical Sentiment Signal: Buy
Current Market Cap: 1225.1B INR
See more data about CIPLA stock on TipRanks’ Stock Analysis page.